Plain-English translation of NCT05953558 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is tracking how well the Micra AV pacemaker performs in everyday patients across France. The Micra AV is a small, leadless pacemaker—meaning it doesn't require wires running through your veins—that can sense your heart's natural rhythm and pace your heartbeat in sync with it. Researchers want to understand how this newer technology works for real patients living with complete heart block.
Traditional pacemakers can cause complications related to their wires and the pocket created under the skin. The Micra AV was designed to avoid these problems by being completely leadless, but doctors want to study how well it actually performs in everyday practice for patients with permanent complete heart block who have normal upper heart chamber function.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be part of a registry—essentially a database—that tracks how you and roughly 1,000 other French patients do with your Micra AV pacemaker over time. You would likely have periodic follow-up visits where doctors check how your device is functioning and how you're feeling. Your health information would be collected and studied to help doctors understand the real-world effectiveness of this treatment.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
France
Paris Sudden Death Expertise Center
Collaborators
CHU de Tours, European Georges Pompidou Hospital
Enrollment target
~1,000 participants
Started
May 2023
Primary completion
November 2023
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 110 Years
Last updated on clinicaltrials.gov in July 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Eloi Marijon, MD,PhD
Paris Sudden Death Expertise Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.